Acute lymphoblastic leukemia overview
You are at the center of everything we do at Seattle Cancer Care Alliance (SCCA). Here, we surround you with a team of specialists who work together closely to provide expertly targeted, complete care and compassionate support throughout your treatment and beyond.
We guide you every step of the way, combining our deep clinical expertise in acute lymphoblastic leukemia (ALL) with a commitment to meet your unique needs.
Why choose SCCA?
Comprehensive ALL treatment
Our doctors are experts in the highly complex, intensive treatment ALL requires. Based on the specific features of your disease, your team may recommend chemotherapy, targeted therapy, immunotherapy or bone marrow transplant, all available at SCCA.
- ALL clinical trials
To give you access to the most innovative therapies, SCCA unites the leading researchers and cancer specialists of Fred Hutch and UW Medicine so you can take part in ALL clinical trials not available everywhere.
Pioneering new approaches
Researchers here pioneered a very important leukemia treatment, bone marrow transplant, and continue to refine it, making transplant an option for more people. We are also advancing ALL chemotherapy and immunotherapy.
Bone marrow transplant for ALL
The Fred Hutch Bone Marrow Transplant Program at SCCA consistently achieves higher-than-expected transplant survival rates. We’ve performed more bone marrow transplants than any other institution in the world. Learn more about bone marrow transplant.
New FDA-approved CAR T-cell therapy
SCCA is one of the first cancer centers in the nation to offer FDA-approved cellular immunotherapy for acute lymphoblastic leukemia. Tisagenlecleucel, known as the brand name Kymriah®, is a CAR T-cell therapy available only at certified treatment centers.
A national leader in cancer care
SCCA is the leading cancer treatment center in the region and among the top nationally, according to U.S. News & World Report.
- Magnet hospital award
University of Washington Medical Center, where our patients receive hospital-based care, has been honored as a Magnet hospital for excellence in nursing, which is linked to better outcomes for patients.
NCI comprehensive cancer center
We are a comprehensive cancer center, a designation from the National Cancer Institute that reflects our scientific leadership and the depth and breadth of our research to prevent, diagnose and treat cancer.
Treatment for acute lymphoblastic leukemia (ALL) is highly complex and intensive, so it’s important to be treated at a specialized center with expertise in ALL. But because the condition is rare, many hospitals and clinics do not have much experience with it.
At SCCA, you receive care from a team of providers with extensive experience in your disease. Your team includes doctors, a team coordinator, a registered nurse, an advanced practice provider and others, based on your needs. You also have access to experts like nutritionists, social workers, acupuncturists, psychiatrists and more who specialize in supporting people with cancer or blood disorders.
For some people, taking part in a clinical study may be the best treatment choice. Access to clinical studies by researchers at SCCA and our founding organizations Fred Hutch and UW Medicine is one reason many patients come to SCCA.
Immunotherapy, which uses your own immune system to recognize and attack cancer cells, is a promising new approach being studied in clinical trials for ALL. Other areas of research include new chemotherapy drugs and new ways to deliver them more effectively.